Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1997-03-11
2000-04-04
Chan, Christina Y.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303911, C07K 1600
Patent
active
060463104
ABSTRACT:
Fas ligand fusion proteins comprising a polypeptide capable of specifically binding an antigen or a cell surface marker are prepared employing recombinant DNA technology for use in, e.g., treatment of autoimmune disorders.
REFERENCES:
patent: 4634664 (1987-01-01), Oestberg
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5266491 (1993-11-01), Nagata et al.
Takahashi et al. Cell vol. 76:969-976, 1994.
S. Nagata et al. (1995) Science 267:1449. The Fas Death Factor.
R. Watanabe-Fukunaga et al. (1992) J. Immunol. 148:1274.
C. Thompson (1995) Science 267:1456. Apoptosis in the Pathogenesis and Treatment of Disease.
B. Trauth et al. (1989) Science 245:301. Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis.
S. Yonehara et al. (1989) J. Exp. Med. 169:1747.
T. Suda et al. (1993) Cell 75:1169.
D. Lynch et al. (1994) Immunity 1:131.
T. Takahashi et al. (1994) Cell 76:969.
T. Takahashi et al. (1994) Internet. Immunol. 6:1567.
T. Griffith et al. (1995) Science 270:1189. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege.
Rouvier et al. (1993) J. Exp. Med. 177:195.
T. Suda and S. Nagata (1994) J. Exp. Med. 179:873.
D. Banner et al. (1993) Cell 73:431.
D. Kagi (1994) Science 265:528. Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity.
S. Nagata and T. Suda (1995) Immunol. Today 16:39.
J. Dhein et al. (1995) Nature 373:438. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95).
D. Bellgrau (1995) Nature 377:630. A role for CD95 ligand in preventing graft rejection.
J. Ogasawara (1993) Nature 364:806. Lethal effect of the anti-Fas antibody in mice.
Bird et al. (1988) Science 242:423. Single-Chain Antigen -Binding proteins.
Fundamental Immunology, W.E. Paul, ed., Raven Press (1993).
Sequences of Proteins of Immunologic Interest, 5th ed., E. Kabat et al., U.S. DHHS, (1991).
M. S. Co et al. (1992) J. Immunol. 148:1149.
J. Sambrook et al. Molecular Cloning: A Laboratory Manual 2nd ed., Cold Spring Harbor Laboratory Press (1989).
E. Harlow et al. Antibodies: A Laboratory Manual Cold Spring Harbor Laboratory (1988).
Methods in Enzymology vol. 182, Guide to Protein Purification, MP Deutscher, ed., Academic Press, (1990).
L. Aguilar-Bryan et al. (1995) Science 268:423. Cloning of the .beta. Cell High-Affinity Sulfonylurea Receptor: A Regulator of Insulin Secretion.
Co. et al. (1996) Cancer Research 56:1118.
C. Elson et al. (1995) Gastroenterology 109:1344.
Queen Cary L.
Schneider William P.
Vasquez Maximiliano
Chan Christina Y.
Nolan Patrick J.
Protein Design Labs., Inc.
LandOfFree
FAS ligand fusion proteins and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FAS ligand fusion proteins and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FAS ligand fusion proteins and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-366386